v3.26.1
SHARE CAPITAL
12 Months Ended
Dec. 31, 2025
SHARE CAPITAL  
SHARE CAPITAL

19.SHARE CAPITAL

(a)

Authorized share capital

The Company’s authorized share capital consists of an unlimited number of common shares without par value and an unlimited number of preferred shares without par value.

(b)

Warrants

The following summarizes information about shares issuable upon the exercise of warrants outstanding during the year.

Warrants classified as equity

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Exercise

​

December 31

​

​

​

​

​

​

​

December 31

Expiry date

  ​ ​ ​

price

  ​ ​ ​

2024

  ​ ​ ​

Issued

  ​ ​ ​

Exercised

  ​ ​ ​

2025

December 18, 2026

 

C$

3.00

 

​

25,540,000

​

​

—

 

​

(16,012,500)

 

​

9,527,500

February 23, 2026

 

C$

7.94

 

​

315,000

​

​

—

 

​

(133,875)

 

​

181,125

Shares issuable upon exercise

​

​

​

​

​

25,855,000

​

​

—

​

​

(16,146,375)

​

​

9,708,625

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted average exercise price

 

​

​

 

C$

3.06

​

C$

—

 

C$

3.04

 

C$

3.09

​

The warrants outstanding at December 31, 2024, were issued when the parent entity’s functional currency was Canadian dollars. Effective February 28, 2025, the functional currency of the parent entity changed to US dollars. However, there were no changes to the contractual terms of the warrants. Consequently, these warrants continue to be accounted for as equity.

​

Subsequent to the reporting period, the Company issued 1,727,142 common shares for proceeds of $4.4 million pursuant to the exercise of warrants.

​

Warrants classified as financial liabilities

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Exercise

  ​ ​ ​

December 31

​

​

​

  ​ ​ ​

​

​

  ​ ​ ​

December 31

Expiry date

  ​ ​ ​

price

  ​ ​ ​

2024

  ​ ​ ​

Issued

  ​ ​ ​

Exercised

  ​ ​ ​

2025

February 28, 2030 (notes 12 and 13(d))

 

C$

11.50

 

​

—

​

​

23,392,397

 

​

—

 

​

23,392,397

Shares issuable upon exercise

 

​

​

 

​

—

​

​

23,392,397

 

​

—

 

​

23,392,397

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted average exercise price

 

​

  ​

 

C$

—

​

C$

11.50

 

C$

—

 

C$

11.50

​

Because the parent entity’s functional currency was US dollars when these warrants were issued and these warrants are exercisable in Canadian dollars, we concluded these were financial liabilities.

​

Subsequent to the reporting period, the Company issued 396,202 common shares for proceeds of $3.3 million pursuant to the exercise of warrants.

​

(c)Dividends

​

The Company declared dividends in the amount of $5.1 million (2024 - nil), or $0.015 per common share during the year ended December 31, 2025. These were paid subsequent to the reporting period.